loader image
Saturday, November 29, 2025
71.1 F
McAllen
- Advertisement -

Danish Studies Find Higher Risk of Optic Nerve Damage with Ozempic

Translate to Spanish or other 102 languages!

Image source: https://creativecommons.org/licenses/by-sa/4.0/  Bgd for illustration purposes
Image source: https://creativecommons.org/licenses/by-sa/4.0/ Bgd for illustration purposes
- Advertisement -

Two large studies from the University of Southern Denmark suggest that the diabetes medication Ozempic doubles the risk of developing NAION, a rare but serious condition that damages the optic nerve.

Drawing on comprehensive data from Danish and Norwegian health registers, the studies validate earlier concerns raised in a smaller American study.

While the absolute risk remains low, researchers suggest the findings should guide discussions between doctors and patients about the benefits and risks of treatment with Ozempic.

- Advertisement -

Two research teams conducted separate studies using different methods to analyze all Danish users of Ozempic.

Follow the link below to read the full story om Medical News Today:

https://www.medicalnewstoday.com/articles/danish-studies-find-higher-risk-optic-nerve-damage-diabetes-drug-ozempic?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-01-03&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×